FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Former DOJ prosecutor charged with stealing confidential Jack Smith investigation documents about Trump

String of burglaries rocking LA residential area committed by South American gangs, DA says

Illegal immigrant truck driver from India arrested in deadly California hit-and-run after Biden release

Vanessa Trump Reveals Scary ‘Personal Health Update’

Trump owns the GOP. Could Republicans pay the price in the midterms?

Owner of daycare in viral Nick Shirley video charged in $4.6M daycare fraud scheme, prosecutors say

Woman Pleads Guilty to Murder of Girl, 2, After Police Find Grisly Box Hidden in Back of Closet

Scientists Spent 20 Years Scaring Our Kids with a Climate Model They Knew Was Flawed

Can Keisha Lance Bottoms deliver the Georgia win Stacey Abrams could not?

Scott Jennings Delivers Reality Check to People Blaming Jews for Thomas Massie’s Loss

New website puts Platner on notice by amplifying scandals: ‘One red flag after another’

Fox News Poll: 30% think recent Trump assassination attempt was staged

Fox News Poll: As economic pain deepens, disapproval of Trump hits new high

AG Todd Blanche Says Raul Castro Will Stand Before US Court, Strongly Suggests US Forces May Be Used to Secure Him

Christopher Rufo Says California Fraud Is Stealing Taxpayer Money on a Scale That Makes Minnesota Look Like ‘Child’s Play’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”